Literature DB >> 28195552

Serum cholesterol acceptor capacity in intrauterine growth restricted fetuses.

Ulrich Pecks1, Werner Rath1, Dirk O Bauerschlag1, Nicolai Maass1, Thorsten Orlikowsky1, Markus G Mohaupt1, Geneviève Escher1.   

Abstract

AIM: Intrauterine growth restriction (IUGR) is an independent risk factor for the development of cardiovascular diseases later in life. The mechanisms whereby slowed intrauterine growth confers vascular risk are not clearly established. In general, a disturbed cholesterol efflux has been linked to atherosclerosis. The capacity of serum to accept cholesterol has been repeatedly evaluated in clinical studies by the use of macrophage-based cholesterol efflux assays and, if disturbed, precedes atherosclerotic diseases years before the clinical diagnosis. We now hypothesized that circulating cholesterol acceptors in IUGR sera specifically interfere with cholesterol transport mechanisms leading to diminished cholesterol efflux.
METHODS: RAW264.7 cells were used to determine efflux of [3H]-cholesterol in response to [umbilical cord serum (IUGR), n=20; controls (CTRL), n=20].
RESULTS: Cholesterol efflux was lower in IUGR as compared to controls [controls: mean 7.7% fractional [3H]-cholesterol efflux, standard deviation (SD)=0.98; IUGR: mean 6.3%, SD=0.79; P<0.0001]. Values strongly correlated to HDL (ρ=0.655, P<0.0001) and apoE (ρ=0.510, P=0.0008), and mildly to apoA1 (ρ=0.3926, P=0.0122) concentrations.
CONCLUSIONS: Reduced cholesterol efflux in IUGR could account for the enhanced risk of developing cardiovascular diseases later in life.

Entities:  

Keywords:  Atherosclerosis; IUGR; cholesterol; efflux; fetal programming; lipids

Mesh:

Substances:

Year:  2017        PMID: 28195552     DOI: 10.1515/jpm-2016-0270

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  5 in total

1.  Hypertensive disease, preterm birth, fetal growth restriction and chronic inflammatory disorders of the placenta: experiences in a single institution with a standardized protocol of investigation.

Authors:  Henning Feist; Simin Bajwa; Ulrich Pecks
Journal:  Arch Gynecol Obstet       Date:  2021-10-24       Impact factor: 2.493

Review 2.  Developmental origins of metabolic diseases.

Authors:  Daniel J Hoffman; Theresa L Powell; Emily S Barrett; Daniel B Hardy
Journal:  Physiol Rev       Date:  2020-12-03       Impact factor: 46.500

3.  Apolipoprotein E Genotype in Very Preterm Neonates with Intrauterine Growth Restriction: An Analysis of the German Neonatal Network Cohort.

Authors:  Stephen Norda; Tanja K Rausch; Thorsten Orlikowsky; Matthias Hütten; Sören Schulz; Wolfgang Göpel; Ulrich Pecks
Journal:  Biomed Res Int       Date:  2017-04-05       Impact factor: 3.411

4.  Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved.

Authors:  Gabriela Loscalzo; Julia Scheel; José Santiago Ibañez-Cabellos; Eva García-Lopez; Shailendra Gupta; José Luis García-Gimenez; Salvador Mena-Mollá; Alfredo Perales-Marín; José Morales-Roselló
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

5.  Estimating fetal cholesterol synthesis rates by cord blood analysis in intrauterine growth restriction and normally grown fetuses.

Authors:  Ulrich Pecks; Verena Bornemann; Anika Klein; Laura Segger; Nicolai Maass; Ibrahim Alkatout; Christel Eckmann-Scholz; Mohamed Elessawy; Dieter Lütjohann
Journal:  Lipids Health Dis       Date:  2019-10-25       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.